{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:06:28Z","timestamp":1773277588362,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T00:00:00Z","timestamp":1432166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T00:00:00Z","timestamp":1432166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1038\/gt.2015.41","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T10:22:58Z","timestamp":1432203778000},"page":"596-601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity"],"prefix":"10.1038","volume":"22","author":[{"given":"A","family":"Rodr\u00edguez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Gil-Hoyos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C A","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L A","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Arias-Badia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A S I","family":"Loskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,21]]},"reference":[{"key":"BFgt201541_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2217\/fmb.09.28","volume":"4","author":"R Alemany","year":"2009","unstructured":"Alemany R, Cascallo M . Oncolytic viruses from the perspective of the immune system. Future Microbiol 2009; 4: 527\u2013536.","journal-title":"Future Microbiol"},{"key":"BFgt201541_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fonc.2014.00188","volume":"4","author":"N Woller","year":"2014","unstructured":"Woller N, Gurlevik E, Ureche CI, Schumacher A, Kuhnel F . Oncolytic viruses as anticancer vaccines. Front Oncol 2014; 4: 188.","journal-title":"Front Oncol"},{"key":"BFgt201541_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1476-4598-12-103","volume":"12","author":"DL Bartlett","year":"2013","unstructured":"Bartlett DL, Liu Z, Sathaiah M, Ravindranathan R, Guo Z, He Y et al. Oncolytic viruses as therapeutic cancer vaccines. Mol Cancer 2013; 12: 103.","journal-title":"Mol Cancer"},{"key":"BFgt201541_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.virol.2011.04.017","volume":"416","author":"H Rodriguez-Rocha","year":"2011","unstructured":"Rodriguez-Rocha H, Gomez-Gutierrez JG, Garcia-Garcia A, Rao XM, Chen L, McMasters KM et al. Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology 2011; 416: 9\u201315.","journal-title":"Virology"},{"key":"BFgt201541_CR5","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1128\/JVI.02032-10","volume":"85","author":"H Jiang","year":"2011","unstructured":"Jiang H, White EJ, Rios-Vicil CI, Xu J, Gomez-Manzano C, Fueyo J . Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J Virol 2011; 85: 4720\u20134729.","journal-title":"J Virol"},{"key":"BFgt201541_CR6","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/mt.2008.141","volume":"16","author":"R Schirmbeck","year":"2008","unstructured":"Schirmbeck R, Reimann J, Kochanek S, Kreppel F . The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens. Mol Ther 2008; 16: 1609\u20131616.","journal-title":"Mol Ther"},{"key":"BFgt201541_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1172\/JCI60202","volume":"122","author":"N Frahm","year":"2012","unstructured":"Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG et al. Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J Clin Invest 2012; 122: 359\u2013367.","journal-title":"J Clin Invest"},{"key":"BFgt201541_CR8","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/jnci\/djt184","volume":"105","author":"P Leone","year":"2013","unstructured":"Leone P, Shin EC, Perosa F, Vacca A, Dammacco F, Racanelli V . MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. J Natl Cancer Inst 2013; 105: 1172\u20131187.","journal-title":"J Natl Cancer Inst"},{"key":"BFgt201541_CR9","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.4049\/jimmunol.172.7.4575","volume":"172","author":"J Lu","year":"2004","unstructured":"Lu J, Higashimoto Y, Appella E, Celis E . Multiepitope trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses. J Immunol 2004; 172: 4575\u20134582.","journal-title":"J Immunol"},{"key":"BFgt201541_CR10","doi-asserted-by":"publisher","first-page":"E659","DOI":"10.1002\/ijc.27362","volume":"131","author":"N Raafat","year":"2012","unstructured":"Raafat N, Sadowski-Cron C, Mengus C, Heberer M, Spagnoli GC, Zajac P . Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope. Int J Cancer 2012; 131: E659\u2013E669.","journal-title":"Int J Cancer"},{"key":"BFgt201541_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1034\/j.1600-0854.2000.010808.x","volume":"1","author":"BC Gil-Torregrosa","year":"2000","unstructured":"Gil-Torregrosa BC, Castano AR, Lopez D, Del Val M . Generation of MHC class I peptide antigens by protein processing in the secretory route by furin. Traffic 2000; 1: 641\u2013651.","journal-title":"Traffic"},{"key":"BFgt201541_CR12","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.161.12.6532","volume":"161","author":"HT Maecker","year":"1998","unstructured":"Maecker HT, Umetsu DT, DeKruyff RH, Levy S . Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. J Immunol 1998; 161: 6532\u20136536.","journal-title":"J Immunol"},{"key":"BFgt201541_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/35019094","volume":"406","author":"G Werlen","year":"2000","unstructured":"Werlen G, Hausmann B, Palmer E . A motif in the alphabeta T-cell receptor controls positive selection by modulating ERK activity. Nature 2000; 406: 422\u2013426.","journal-title":"Nature"},{"key":"BFgt201541_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1084\/jem.188.2.277","volume":"188","author":"WW Overwijk","year":"1998","unstructured":"Overwijk WW, Tsung A, Irvine KR, Parkhurst MR, Goletz TJ, Tsung K et al. gp100\/pmel 17 is a murine tumor rejection antigen: induction of \"self\"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J Exp Med 1998; 188: 277\u2013286.","journal-title":"J Exp Med"},{"key":"BFgt201541_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/gt.2011.106","volume":"19","author":"JJ Rojas","year":"2011","unstructured":"Rojas JJ, Gimenez-Alejandre M, Gil-Hoyos R, Cascallo M, Alemany R . Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD. Gene Ther 2011; 19: 453\u2013457.","journal-title":"Gene Ther"},{"key":"BFgt201541_CR16","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1038\/mt.2010.173","volume":"18","author":"JJ Rojas","year":"2010","unstructured":"Rojas JJ, Guedan S, Searle PF, Martinez-Quintanilla J, Gil-Hoyos R, Alcayaga-Miranda F et al. Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses. Mol Ther 2010; 18: 1960\u20131971.","journal-title":"Mol Ther"},{"key":"BFgt201541_CR17","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1089\/hum.2009.038","volume":"20","author":"N Bayo-Puxan","year":"2009","unstructured":"Bayo-Puxan N, Gimenez-Alejandre M, Lavilla-Alonso S, Gros A, Cascallo M, Hemminki A et al. Replacement of adenovirus type 5 fiber shaft heparan sulfate proteoglycan-binding domain with RGD for improved tumor infectivity and targeting. Hum Gene Ther 2009; 20: 1214\u20131221.","journal-title":"Hum Gene Ther"},{"key":"BFgt201541_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)80447-1","volume":"6","author":"A Porgador","year":"1997","unstructured":"Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN . Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 1997; 6: 715\u2013726.","journal-title":"Immunity"},{"key":"BFgt201541_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cellimm.2004.04.006","volume":"228","author":"S Agrawal","year":"2004","unstructured":"Agrawal S, Reemtsma K, Bagiella E, Oluwole SF, Braunstein NS . Role of TAP-1 and\/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma. Cell Immunol 2004; 228: 130\u2013137.","journal-title":"Cell Immunol"},{"key":"BFgt201541_CR20","first-page":"1095","volume":"61","author":"B Seliger","year":"2001","unstructured":"Seliger B, Wollscheid U, Momburg F, Blankenstein T, Huber C . Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells. Cancer Res 2001; 61: 1095\u20131099.","journal-title":"Cancer Res"},{"key":"BFgt201541_CR21","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1016\/j.vaccine.2010.03.007","volume":"28","author":"M Martini","year":"2010","unstructured":"Martini M, Testi MG, Pasetto M, Picchio MC, Innamorati G, Mazzocco M et al. IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer. Vaccine 2010; 28: 3548\u20133557.","journal-title":"Vaccine"},{"key":"BFgt201541_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/00002371-200405000-00002","volume":"27","author":"HT Khong","year":"2004","unstructured":"Khong HT, Wang QJ, Rosenberg SA . Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression. J Immunother 2004; 27: 184\u2013190.","journal-title":"J Immunother"},{"key":"BFgt201541_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0092-8674(88)91043-4","volume":"54","author":"MW Moore","year":"1988","unstructured":"Moore MW, Carbone FR, Bevan MJ . Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988; 54: 777\u2013785.","journal-title":"Cell"},{"key":"BFgt201541_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1084\/jem.185.2.317","volume":"185","author":"C Winzler","year":"1997","unstructured":"Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997; 185: 317\u2013328.","journal-title":"J Exp Med"},{"key":"BFgt201541_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2144\/000112993","volume":"45","author":"RJ Stanton","year":"2008","unstructured":"Stanton RJ, McSharry BP, Armstrong M, Tomasec P, Wilkinson GW . Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function. Biotechniques 2008; 45: 659\u2013662; 64\u201368.","journal-title":"Biotechniques"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201541.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201541","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201541.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T19:37:50Z","timestamp":1691696270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,21]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["BFgt201541"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.41","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,21]]},"assertion":[{"value":"20 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}